Marché du traitement de la constipation – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00005408
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 175
Buy Now

[Rapport de recherche]Le marché du traitement de la constipation devrait atteindre 13 386,19 millions de dollars américains en 2027 contre 8 533,89 millions de dollars américains en 2019. Le marché devrait croître avec un TCAC de 5,9 % entre 2020 et 2027.



La constipation est un trouble chronique qui entraîne des selles indifférentes et conduit généralement à des selles durcies qui persistent pendant plusieurs semaines, voire plus. Cela se produit généralement lorsque le côlon a absorbé une quantité excessive d'eau de la nourriture qui se trouve dans le côlon.



Le rapport offre des informations et une analyse approfondie du marché du traitement de la constipation, en mettant l'accent sur divers paramètres tels que les tendances du marché, avancées technologiques, dynamique du marché et analyse du paysage concurrentiel des principaux acteurs du marché mondial. Le marché a été segmenté en fonction de la thérapeutique, de la maladie, du canal de distribution et de la région. Basé sur la région, le marché est segmenté en Amérique du Nord, en Europe, en Asie-Pacifique, au Moyen-Orient et en Afrique, et en Amérique du Sud et centrale.



Régions lucratives pour le marché du traitement de la constipation



Aperçu du marché



Prévalence croissante de la constipation chronique



La constipation est un problème de santé couramment observé chez tous groupes d'âge à travers le monde. Selon l'article ‘Chronic Constipation publié en mai 2018, dans le monde, la prévalence de la constipation est estimée à 16%. On estime qu'il varie entre 0,7 % et 79 %. De plus, la prévalence de la constipation est plus élevée chez les personnes âgées de 60 ans et plus. La prévalence de la constipation attribuée à ce groupe d'âge est de 33,5 %.



Plusieurs facteurs sont associés à la prévalence croissante chez les personnes âgées, notamment l'absence de selles normales en raison de l'âge progressif, d'une mauvaise alimentation et d'un apport hydrique inapproprié, et une activité physique insuffisante. Alors que chez les adultes, la cause courante de la constipation est le stress, le manque d'exercice, les troubles endocriniens, les maladies du côlon, les dysfonctionnements neurologiques et d'autres causes telles que les conditions environnementales et pharmaceutiques.



La prévalence de la constipation dans le monde varie considérablement en raison des différents groupes ethniques et des perceptions. Par exemple, selon l'article ‘Quelle est la prévalence mondiale de la constipation ? publié en mars 2020, en Amérique du Nord, ~63 millions de personnes sont touchées par la constipation chronique. De même, environ 12 % des personnes à travers le monde vivent avec une constipation auto-définie. Les données ont également indiqué que les personnes dans les Amériques et l'Asie-Pacifique la prévalence est le double de la région européenne. La constipation entraîne une morbidité psychologique et entraîne une mauvaise qualité de vie. Ainsi, il est essentiel de diagnostiquer, gérer et traiter la constipation est très important. Par conséquent, la prévalence croissante de la constipation devrait stimuler la demande de médicaments traitant la constipation, conduire davantage à la croissance du marché.



Aperçus à base thérapeutique



Basé sur la thérapeutique, le Le marché du traitement de la constipation est segmenté en laxatifs, activateurs des canaux chlorure, antagonistes des récepteurs mu-opioïdes à action périphérique, agonistes GC-C et agonistes des récepteurs 5-HT4. Le segment des laxatifs détenait la plus grande part du marché en 2019. Cependant, le segment des agonistes GC-C devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



Marché du traitement de la constipation, par thérapeutique - 2019 et 2027



Disease Insights



Sur la base de la maladie, le marché du traitement de la constipation est segmenté en constipation idiopathique chronique, syndrome du côlon irritable avec constipation et constipation induite par les opioïdes. Le segment de la constipation idiopathique chronique détenait la plus grande part du marché en 2019 et on estime qu'il a enregistré le TCAC le plus élevé du marché au cours de la période de prévision.



Aperçu des canaux de distribution



Basé sur canal de distribution, le marché du traitement de la constipation est segmenté en pharmacies hospitalières, pharmacies de détail et pharmacies en ligne. Le segment des pharmacies de détail détenait la plus grande part du marché en 2019 et on estime qu'il a enregistré le TCAC le plus élevé de 6,4 % sur le marché au cours de la période de prévision.



Perspectives stratégiques



Inorganiques des stratégies telles que les partenariats, les fusions et les acquisitions sont couramment adoptées par les entreprises pour répondre à l'évolution de la demande des clients dans le monde entier, ce qui leur permet également de conserver leur marque. Les acteurs du marché du traitement de la constipation ont adopté des stratégies organiques telles que les lancements et les extensions de produits pour étendre leur empreinte et leurs portefeuilles de produits.



Par Thérapeutique




  • Laxatifs

  • Activateurs des canaux chlorure

  • Antagonistes des récepteurs mu-opioïdes à action périphérique

  • Agonistes de la GC-C

  • Agonistes des récepteurs 5-HT4


< p>Par maladie




  • Constipation chronique idiopathique

  • Syndrome du côlon irritable avec constipation

  • Constipation induite par les opioïdes


Par canal de distribution




  • Pharmacies hospitalières

  • Pharmacies de détail

  • Pharmacies en ligne


Par zone géographique


  • Amérique du Nord

    • États-Unis

    • Canada

    • Mexique



  • Europe
    • France

    • Allemagne

    • Italie

    • Royaume-Uni

    • Espagne



  • < li>Asie-Pacifique (APAC)

    • Chine

    • Inde

    • Corée du Sud

    • Japon

    • Australie


  • Moyen-Orient et Afrique (MEA)

    • Afrique du Sud

    • Arabie saoudite

    • EAU


    • Amérique du Sud et centrale (SCAM)

      • Brésil

      • Argentine




    Profils d'entreprise




    • AbbVie's Inc

    • Takeda Pharmaceutical Company Limited

    • Bausch Health Companies Inc.

    • Bayer AG

    • Mallinckrodt Plc

    • Abbott

    • Cosmo Pharma

    • Sanofi

    • Albireo Pharma, Inc,

    • AstraZeneca


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is a constipation treatment?

Constipation is a chronic disorder that leads to indifferent bowel movements, usually leading to hardened faeces that persist for several weeks or even longer. This usually happens when the colon absorbs excessive water from the colon food.

What are the driving factors for the constipation treatment market across the globe?

Key factors that are driving growth of the market are increasing research and development for the development of new drugs, improving healthcare infrastructure in various emerging economies, increasing awareness among end-users, growing geriatric population, increasing fast-food consumption and unhealthy lifestyle.

At what cost the drugs are available to treat constipation?

The product's cost varies depending upon the type of drugs, such as branded (innovative) or generic and form such as tablets, syrup, and powder. The price of products also varies depending upon the countries. For instance, the cost of Amitiza oral capsule 8 mg is the ~ US $397 for 60 capsules in the US. Whereas the price for laxative is different from the tablet, for instance, MOVICOL 1 sachet is US$ 0.80 (83.90 yen) in Japan. Similarly, the price of Dulcolax Laxative Tablets for 50 tablets is nearly US$ 6, whereas it cost US$ 0.94 (0.80 €) for one tablet.

The List of Companies - Constipation Treatment Market

  1. AbbVie Inc.
  2. Takeda Pharmaceutical Company Limited
  3. Bausch Health
  4. Bayer AG
  5. Mallinckrodt
  6. Abbott
  7. COSMO PHARMACEUTICALS
  8. Sanofi
  9. Albireo Pharma, Inc
  10. AstraZeneca

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports